This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients.
This study was designed as a single-center retrospective analysis aimed at investigating whether COVID-19 infection increases the risk or burden of radiation-induced pneumonitis in breast cancer patients. Breast cancer patients who underwent radiotherapy at the Cancer Center of Zhejiang Hospital between January 1, 2021, and June 30, 2024, were screened for eligibility. Patients who met the inclusion criteria were identified through the hospital information system, and their clinical records were reviewed. Follow-up was conducted via telephone interviews.
Study Type
OBSERVATIONAL
Enrollment
200
The COVID-19 infection situation was used as an intervention measure, and the cohort was divided into groups.
Zhejiang Hospital, Department of Oncology, Hangzhou, China, 310030
Hangzhou, Zhejiang, China
Radiation Pneumonitis Situation
The incidence rate, severity and onset time of radiation pneumonitis
Time frame: From January 2021 to June 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.